Bristol Myers Squibb buys schizophrenia drug developer for $14 billion
American pharmaceutical company Bristol Myers Squibb announced on signing an agreement to purchase biopharmaceutical Karuna Therapeutics, which, among other things,...
American pharmaceutical company Bristol Myers Squibb announced on signing an agreement to purchase biopharmaceutical Karuna Therapeutics, which, among other things,...
The American pharmaceutical company Bristol Myers Squibb (BMS) has entered into an agreement to purchase Mirati Therapeutics, which is developing...
Eli Lilly became the second American pharmaceutical manufacturer after Bristol-Myers Squibb (BMS) to leave Russia for good. The company can...